These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26627044)

  • 1. Macular Atrophy Progression and 7-Year Vision Outcomes in Subjects From the ANCHOR, MARINA, and HORIZON Studies: The SEVEN-UP Study.
    Brijesh T; Shorya A
    Am J Ophthalmol; 2016 Feb; 162():200. PubMed ID: 26627044
    [No Abstract]   [Full Text] [Related]  

  • 2. Macular atrophy progression and 7-year vision outcomes in subjects from the ANCHOR, MARINA, and HORIZON studies: the SEVEN-UP study.
    Bhisitkul RB; Mendes TS; Rofagha S; Enanoria W; Boyer DS; Sadda SR; Zhang K
    Am J Ophthalmol; 2015 May; 159(5):915-24.e2. PubMed ID: 25640411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reply.
    Bhisitkul RB; Mendes TS; Rofagha S; Enanoria W; Boyer DS; Sadda SR; Zhang K
    Am J Ophthalmol; 2016 Feb; 162():200-1. PubMed ID: 26621610
    [No Abstract]   [Full Text] [Related]  

  • 4. Fellow Eye Comparisons for 7-Year Outcomes in Ranibizumab-Treated AMD Subjects from ANCHOR, MARINA, and HORIZON (SEVEN-UP Study).
    Bhisitkul RB; Desai SJ; Boyer DS; Sadda SR; Zhang K
    Ophthalmology; 2016 Jun; 123(6):1269-77. PubMed ID: 26996339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
    Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Driving ability reported by neovascular age-related macular degeneration patients after treatment with ranibizumab.
    Bressler NM; Chang TS; Varma R; Suñer I; Lee P; Dolan CM; Ward J; Ianchulev T; Fine J
    Ophthalmology; 2013 Jan; 120(1):160-8. PubMed ID: 23009891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of fellow eye visual acuity on visual acuity of study eyes receiving ranibizumab for age-related macular degeneration.
    Zweifel SA; Saroj N; Shapiro H; Freund KB
    Retina; 2012 Jul; 32(7):1243-9. PubMed ID: 22466461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographic atrophy in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
    Xu L; Mrejen S; Jung JJ; Gallego-Pinazo R; Thompson D; Marsiglia M; Freund KB
    Retina; 2015 Feb; 35(2):176-86. PubMed ID: 25387047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of retinal pigment epithelial atrophy in antiangiogenic therapy of neovascular age-related macular degeneration.
    Schütze C; Wedl M; Baumann B; Pircher M; Hitzenberger CK; Schmidt-Erfurth U
    Am J Ophthalmol; 2015 Jun; 159(6):1100-1114.e1. PubMed ID: 25769245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective hospital-based analysis of age-related macular degeneration patterns in India: 5-year follow-up.
    Sudhalkar A; Sethi V; Gogte P; Bondalapati S; Khodani M; Chhablani JK
    Indian J Ophthalmol; 2015 Dec; 63(12):899-904. PubMed ID: 26862094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neovascular age-related macular degeneration: is it worthwhile treating an eye with poor visual acuity, if the visual acuity of the fellow eye is good?
    Rasmussen A; Fuchs J; Hansen LH; Larsen M; Sander B; Lund-Andersen H
    Eye (Lond); 2017 Jun; 31(6):978-980. PubMed ID: 28106891
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term visual outcome and prognostic factors of Intravitreal anti-vascular endothelial growth factor treatment for retinal angiomatous proliferation.
    Cho HJ; Lee TG; Han SY; Kim HS; Kim JH; Han JI; Lew YJ; Kim JW
    Graefes Arch Clin Exp Ophthalmol; 2016 Jan; 254(1):23-30. PubMed ID: 25825231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PROGRESSION OF MACULAR ATROPHY IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION UNDERGOING ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
    Abdelfattah NS; Zhang H; Boyer DS; Sadda SR
    Retina; 2016 Oct; 36(10):1843-50. PubMed ID: 27135213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.
    Chew EY; Clemons TE; Agrón E; Sperduto RD; Sangiovanni JP; Davis MD; Ferris FL;
    JAMA Ophthalmol; 2014 Mar; 132(3):272-7. PubMed ID: 24385141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration.
    Marsiglia M; Boddu S; Chen CY; Jung JJ; Mrejen S; Gallego-Pinazo R; Freund KB
    Retina; 2015 May; 35(5):966-74. PubMed ID: 25627089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of outcomes from a phase 3 study of age-related macular degeneration with a matched, observational cohort.
    Gillies MC; Walton RJ; Arnold JJ; McAllister IL; Simpson JM; Hunyor AP; Guymer R; Essex RW; Morlet N; Barthelmes D
    Ophthalmology; 2014 Mar; 121(3):676-81. PubMed ID: 24290801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term results in neovascular age-related macular degeneration : Changes in visual acuity and geographic atrophy during long-standing anti-VEGF therapy].
    Thalgott V; Feucht N; Lohmann CP; Maier M
    Ophthalmologe; 2016 Aug; 113(8):668-74. PubMed ID: 26920612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual outcomes in relation to time to treatment in neovascular age-related macular degeneration.
    Real JP; Luna JD
    Acta Ophthalmol; 2016 Dec; 94(8):e803. PubMed ID: 27417383
    [No Abstract]   [Full Text] [Related]  

  • 19. TREATMENT OUTCOMES FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION PATIENTS WITH INITIAL VISION BETTER THAN 20/40 USING A TREAT-AND-EXTEND REGIMEN.
    Rahimy E; Rayess N; Ho AC; Regillo CD
    Retina; 2016 May; 36(5):875-80. PubMed ID: 26630316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative assessment of central retinal thickness in recurrent neovascular age-related macular degeneration.
    Chee Yee C; Papakostas TD; Vavvas DG
    Br J Ophthalmol; 2014 Sep; 98(9):1308. PubMed ID: 24997184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.